Concepedia

Author

Ruozheng Wang

Xinjiang Medical UniversityORCID

Also Known As

RUO ZHENG WANG, RUOZHENG WANG, Ruo-Zheng Wang, Ruo-zheng Wang, Ruozheng Wang, Ruo‐Zheng Wang

73

Publications

988

Citations

13

H-Index

14

Concepts

All Affiliations

Xinjiang Medical UniversityTumor Hospital of Xinjiang Medical UniversityChinese Academy of Medical Sciences & Peking Union Medical CollegeSun Yat-sen UniversitySun Yat-sen University Cancer Center
RW

About

Ruozheng Wang is an author at Xinjiang Medical University specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

61

2

Pathology

2

2

30

3

Cell Biology

1

1

17

4

Immunology

1

1

13

5

Surgical Oncology

1

1

31

Ruozheng Wang

×

17

Publications

864

Citations

13

H-Index

YearCitations

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Ling‐Long Tang, Yu‐Pei Chen, Chuanben Chen,

Cancer Communications

2021

374

Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway

Chun-Li Da, Yuting Liu, Yiyi Zhan,

Oncology Reports

2016

82

Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses

Megat Abd Hamid, Ruozheng Wang, Xuan Yao,

Cancer Immunology Research

2019

74

B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma

Tingting Yu, Tao Zhang, Xi Lü,

OncoTargets and Therapy

2018

55

A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening

Yong‐Qiao He, Tong‐Min Wang, Mingfang Ji,

Nature Communications

2022

48

Detection of methylation status of Epstein‐Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma

Xiao‐Hui Zheng, Ruozheng Wang, Xi‐Zhao Li,

Cancer Science

2019

38

Dosimetric research on intensity-modulated arc radiotherapy planning for left breast cancer after breast-preservation surgery

Yong Yin, Jinhu Chen, Tao Sun,

Medical dosimetry

2012

31

Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH

Guanzhong Gong, Ruozheng Wang, Yüjie Guo,

Radiation Oncology

2013

28

Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes

Meng Liu, Haiyin An, Yuan Zhang,

EBioMedicine

2020

20

ELK1 Promotes Epithelial‐Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7‐H3

Tingting Yu, Tao Zhang, Fei Su,

Oxidative Medicine and Cellular Longevity

2021

20

Page 1